Invention Grant
- Patent Title: Substituted isoquionline derivatives as immunomudulators
-
Application No.: US16499009Application Date: 2018-03-26
-
Publication No.: US11046675B2Publication Date: 2021-06-29
- Inventor: Kap-Sun Yeung , Denis R. St. Laurent , Jeffrey Lee Romine , Paul Michael Scola
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- International Application: PCT/US2018/024288 WO 20180326
- International Announcement: WO2018/183171 WO 20181004
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D401/12 ; C07D401/14 ; C07D405/12 ; A61K45/06
Abstract:
The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various pp diseases, including cancer and infectious diseases. (I)
Public/Granted literature
- US20200181125A1 SUBSTITUTED ISOQUIONLINE DERIVATIVES AS IMMUNOMUDULATORS Public/Granted day:2020-06-11
Information query
